Duke University Immunologist Buckley Is Cited For Transplantation Research

Rebecca H. Buckley, J. Buren Sidbury Professor of Pediatrics and chief of pediatric allergy and immunology at Duke University Medical Center, Durham, N.C., has received the 29th annual National Board Award, recognizing a woman scientist or physician who has made significant contributions to health care. It is presented by the Philadelphia-based Medical College of Pennsylvania, the United States' first medical school for women. Buckley received the college's Presidential Medal and a $5,000 resea

Written byBarbara Spector
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Buckley, 58, developed bone marrow transplant therapies for severe combined immunodeficiency disease (SCID). Before her work in 1982, only perfectly matched siblings of SCID infants could be bone marrow donors. Most afflicted babies did not have matched donors.

"It was horrible because they all died within a few weeks of being diagnosed," Buckley says.

In 1982, Buckley and colleagues found that transplants involving stem cells rather than mature T cells pose little threat of graft-versus-host disease (Journal of Immunology, 136:2398-2407, 1986). Since that discovery, Buckley has reported that her group has been able to save about 75 percent of 45 marrow-transplant infants without matched donors.

Buckley is also known for her work in allergic diseases. She published the first report of hyperimmunoglobulinemia E, also known as Buckley syndrome (Pediatrics, 49: 59-70, 1972). "People joke about it and say it's just a trivial problem--but that's a misconception that people have," she ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies